Policy and Basic Approach
The main purposes of occupational health are to prevent the health disorders caused by harmful factors in the workplace, while working to maintain and promote the health of employees. In addition to complying with the Occupational Health and Safety Act and related laws and regulations, the Company believes that encouraging employee health promotion leads to the happiness of employees and their families and that for employees to be energetically active in their local communities, including after retirement, is a corporate social responsibility and thus promotes occupational health. At the same time, the Company believes that healthy employees make for healthy organizations and contribute to an improvement in the Company’s labor productivity, and we are thus working to improve both the well-being of our employees and the organizational culture.
Under the Mitsui Chemicals Group Responsible Care Policy, we actively promote the well-being of all our employees. In addition, under Company rules (occupational health regulations) that pertain to occupational health management, set forth in our basic items that also cover occupational health, we have developed the basic philosophy of “Employee well-being is directly linked to the Company’s well-being.” Based on this, we actively work to develop occupational health measures, including for health management.
System and Responsible Officers
With the responsible director in charge of the Human Resources Division, the industrial physician who heads the Health Management Department (supervising industrial physician) in the Human Resources Division implements concrete measures. Leading by the supervising industrial physician, we hold regular Group-wide industrial physician conferences to consider issues and measures related to health management. Based on these conferences, we formulate occupational health plans during the fiscal year and proposals for annual plan key issues and measures (Group-wide occupational health key issues), which are decided through deliberations by the Responsible Care Committee. In addition, the Head Office, Sodegaura Center, and the healthcare sections of all five of our Works take the lead in drawing up and expanding occupational health annual plans for each business site and each business site reports its progress at the industrial physician conferences.
At each business site, full-time industrial physicians, nursing staff and health supervisors at healthcare sections promote efforts to improve employee health and measures designed to prevent employees from being exposed to harmful substances. We also maintain Group-wide statistics on the rate of lifestyle-related disease rates, number of days off due to illness, number of days of mental health disorders, number of new cases of mental health disorders, working environment measurement results, and hazardous materials risk assessment results. We assign part-time industrial physicians, nursing staff, and other healthcare professionals to our smaller Works and to major Works operated by our subsidiaries and affiliates, in an effort to help improve the health of all Group employees.
The relevant persons and labor union members at each Mitsui Chemicals site hold a health and safety committee meeting for each site, in which they participate and at which they report on and discuss issues related to occupational health, including the maintenance and promotion of health, workplace environments and long working hours.
- Dissemination of the Responsible Care Policy
As well as disseminating the Responsible Care Policy to overseas affiliates, we broadcast the CEO Message for National Occupational Health Week.
- Occupational health survey and audit
Mitsui Chemicals submits the Management Check List regarding to occupational health to affiliates that produce or handle chemical substances to assess their health management status in workplaces. Further, we undertake an occupational health audit in each of the affiliates’ works every four years, and in overseas affiliates every five years, except in the U.S., Europe, and Singapore. The audited companies are notified of the audit results and are requested to correct any problems identified. If a company is requested to make corrections, it is subject to a follow-up audit after one year to confirm the correction progress.
Domestic affiliates share information related to occupational health in the meeting of those in charge of HR at domestic subsidiaries and affiliates held every six months. The information provided in the meeting includes changes in occupational health-related laws and regulations with notes on such changes, and details of occupational health issues within the Group.
- Offering occupational health-related services
We are receiving an increasing number of requests from domestic affiliates to provide occupational health-related services of the same high quality as in Mitsui Chemicals itself. We are currently working to establish occupational health measures through close collaborations among Mitsui Chemicals and the affiliates. In these measures, Mitsui Chemicals and some affiliates are concluding comprehensive occupational health service contracts whereby the Health Management Department in Mitsui Chemicals directly provides these affiliates with the same health services as offered to employees of Mitsui Chemicals.
Goals and Results
Health and Productivity Management
|Frequency of absences from work due to health disorders||Mitsui Chemicals, Inc. registered employees||Less than 0.6||0.78||✕||Less than 0.69||0.5 or less|
|Frequency of absences from work due to mental health disorders||Mitsui Chemicals, Inc. registered employees||Less than 0.30||0.45||✕||Less than 0.37||0.25 or less|
|Average rate of lifestyle-related disease||Mitsui Chemicals, Inc. registered male employees||Less than 9.0％||9.7%||✕||Less than 9.4%||8.0% or less|
|Ratio of smokers||Mitsui Chemicals, Inc. registered employees||24.7% or less||24.2%||◯||23.2 or less||20% or less|
Preventing Exposure to Harmful Substances
|Working environment measurement result relating to harmful substances||Mitsui Chemicals, Inc.||Management Category I 100%||100%||〇||Management Category I 100%||Management Category I 100%|
|Harmful substance risk assessment implementation rate: (New substances being handled and SDS-updated substances)||Mitsui Chemicals, Inc.||100%||100%||〇||100%||─|
Review and Challenges
Together with enhancing health as an important occupational health-related issue, there is a concern with an increase in the rate of lifestyle-related disease. Looking at lifestyle-related disease risks, however, we see that there is an improvement in the blood pressure and blood sugar trends. In accordance with the increase in the obesity rate among young people, the overall number of obese people has been increasing, and we have positioned measures to combat obesity as an important issue. In particular, we are focusing on health promotion among young employees, and have already observed positive results on obesity prevention for such employees. Mental health measures also represent an important health issue for employees and have an enormous impact on labor productivity. Utilizing stress level investigations is a way we will work to further raise the level of improvements in the workplace environment.
With regard to the promotion of policies to prevent the exposure of chemical substances, risk assessment measures concerning hazardous materials and the reinforcement of measures are being sought in line with revisions to the Occupational Health and Safety Act. By the end of fiscal 2018, we plan to finish the risk assessment for inhalant chemicals and conduct an individual exposure measurement after establishing a new risk assessment method that reinforces the existing method. We are thus implementing risk reduction measures. We also completed the establishment of a risk assessments relating to the hazards posed by chemical substances from being absorbed through the skin in fiscal 2018. From fiscal 2019, we will systematically conduct risk assessments for absorption of chemicals through the skin while continuing to promote risk reduction concerning inhalant chemicals.